We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific Sees Mid-2007 FDA Audit of Stent Operations
Boston Scientific Sees Mid-2007 FDA Audit of Stent Operations
April 5, 2007
Boston Scientific anticipates that it will be ready for the FDA to audit its drug-eluting stent manufacturing operations and compliance systems by mid-2007, according to Chief Operating Officer Paul LaViolette.